Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.80
-0.29 (-4.09%)
At close: Apr 28, 2026, 4:00 PM EDT
6.85
+0.05 (0.74%)
After-hours: Apr 28, 2026, 6:05 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $180.26 million as of April 28, 2026. Its market cap has decreased by -34.79% in one year.
Market Cap
180.26M
Enterprise Value
70.58M
1-Year Change
-34.79%
Ranking
Category
Stock Price
$6.80
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $180.26M, an increase of 8.55%. That is a compound annual growth rate of 3.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 179.86M | -4.07% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MacroGenics | 192.27M |
| Humacyte | 188.16M |
| Canton Strategic Holdings | 186.97M |
| Korro Bio | 184.61M |
| Precision BioSciences | 183.59M |
| Unicycive Therapeutics | 180.95M |
| Tonix Pharmaceuticals Holding | 180.55M |
| Acumen Pharmaceuticals | 177.64M |